Amongst the recently rising rosacea treatments, botulinum toxin has attracted notice for its potential efficacy in providing as many as 4 months of symptomatic reduction. Xeomin® appears to show a dose ratio with Botox® of one:one.33 No significant discrepancies in protection and efficacy are found in scientific tests evaluating https://botulinum-toxins20527.blogs-service.com/66513831/what-does-different-types-of-botulinum-toxins-mean